Phathom Pharmaceuticals, Inc. - Common Stock — Stato Patrimoniale (NASDAQ:PHAT) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 295.11 M189.43 M164.81 M413.84 M378.32 M259.15 M Totale passività 100.84 M117.28 M239.62 M486.6 M631.9 M697.32 M Patrimonio netto totale 194.27 M72.16 M-74.81 M-72.76 M-253.58 M-438.17 M Totale passività e patrimonio netto 295.11 M189.43 M164.81 M413.84 M378.32 M259.15 M Debito totale 39.63 M89.67 M95.26 M137.84 M201.41 M209.09 M Indebitamento netto 39.63 M89.67 M95.26 M137.84 M201.41 M79.11 M

Notizie

Phathom Pharmaceuticals supera le aspettative EPS del Q1 2026

Phathom T1 2026: ricavi raddoppiano, redditività in vista

Phathom Pharmaceuticals supera le aspettative sull’EPS nel Q1 2026

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Rocket Pharmaceuticals e Argan salgono nel premarket; Two Harbors in lieve calo

Barclays alza il rating di Phathom Pharmaceuticals per le prospettive di fatturato

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript